from Reuters: Health News https://reut.rs/2Go2ZQs
Tuesday, February 12, 2019
Clinigen buys U.S. rights to Novartis' cancer drug Proleukin
British pharmaceutical firm Clinigen Group Plc said on Wednesday it acquired the U.S. rights to Swiss drugmaker Novartis AG's skin and lung cancer drug Proleukin for a total of $210 million, including some future payments.
from Reuters: Health News https://reut.rs/2Go2ZQs
from Reuters: Health News https://reut.rs/2Go2ZQs
Subscribe to:
Post Comments (Atom)
-
WEIGHT LOSS supplements could help overweight or obese patients with the diet plans. You could lose weight and avoid weight gain by adding...
-
A 37-YEAR-OLD mum was told she was too young to develop bowel cancer. Terrifyingly, the disease was only diagnosed when it reached stage f...
-
SUPPLEMENTS could be used to prevent cold symptoms, as well as to lower the risk of flu signs. Adding these cheap capsules to your diet ev...
No comments:
Post a Comment